Results 161 to 170 of about 59,301 (217)

Development and validation of machine learning-based prediction for in-hospital mortality in ICU patients with severe community-acquired pneumonia and respiratory failure. [PDF]

Front Med (Lausanne)
Zheng X, Wang B, Yuan L, Liu X, Xu Y, Sun B.   +5 more
europepmc   +1 more source

Hospital at Home in 10 years—Here, borrow my binoculars

Journal of Internal Medicine, Volume 300, Issue 2, Page 153-163, August 2026.
Abstract Hospital in the Home (HAH) refers to the delivery of acute hospital care to patients at home, or in their usual place of care, including nursing homes. HAH is an acute hospital substitution service—it delivers medical, nursing and allied health staff, skills, interventions and treatments, technologies and supervision usually found in hospitals
Michael Montalto
wiley   +1 more source

Living Microbial Drugs

Chemistry – A European Journal, Volume 32, Issue 26, 11 July 2026.
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker   +3 more
wiley   +1 more source

Erratum: Impact of the corona virus disease 2019 pandemic on the prevalence of common respiratory pathogens in hospitalized young patients with non-severe community-acquired pneumonia. [PDF]

J Thorac Dis
Editorial Office.
europepmc   +1 more source

Lung and gut microbiota profiling in severe community acquired pneumonia patients: a prospective pilot study. [PDF]

Front Microbiol
Zou W, Zheng R, Lin S, Lu C, Xie B.
europepmc   +1 more source

Targeted next-generation sequencing analysis of pathogens and microecology in pediatric lower respiratory tract infections identifies risk factors for severe community-acquired pneumonia. [PDF]

Front Cell Infect Microbiol
Pi H, Lin H, Zhou J, Liu H, Liang S, Zhu R, Li D, Lu X, Yang M, Chen H, Li Y.   +10 more
europepmc   +1 more source

Lung microbiome signatures and explainable predictive modeling of glucocorticoid response in severe community acquired pneumonia. [PDF]

Front Microbiol
Cheng YN, Chen GT, Huang WC, Chiu YP, Tang Y, Fu PK, Lee TY.   +6 more
europepmc   +1 more source

Thirty-day hospital readmission and its determinants among patients with severe community-acquired pneumonia: a prospective cross-sectional study in Northwest Ethiopia. [PDF]

BMC Infect Dis
Tekle MT, Jara AG, Sema FD.
europepmc   +1 more source

Development and validation of a machine learning model for critical progression risk in pediatric severe community-acquired pneumonia. [PDF]

Sci Rep
Ma X, Zhao W, Sun Q, Hang H, Li M, Wu D, Liu B, Zhu H.   +7 more
europepmc   +1 more source

Heterogeneity in the Association Between Pneumococcal Vaccination and the Risk of Severe Community-Acquired Pneumonia in Elderly Inpatients: A Causal Forest Analysis. [PDF]

Vaccines (Basel)
Lan Y, Xin Z, Lin Z, Li J, Xie X, Xiong Y, Zhang D.   +6 more
europepmc   +1 more source